We are the CGMP outsourcing facility of choice for admixing, compounding and specialty products, providing the very best patient care in North America.
Our team will deliver the highest quality admixing, compounding and specialty products from our CGMP outsourcing facility. Each employee is charged with an uncompromising commitment to excellence in quality and safety. We believe our only priority is to ensure patient safety, total trust of practitioners and the full confidence of regulatory agencies.
We are firmly obligated to our patients, healthcare providers and to all others who use our products and services. We are committed to delivering the highest quality possible. We will constantly apply the most cost efficient operations to maintain reasonable prices. The empowerment and innovation of our employees will be the foundation of the company and provide successful career advancement. Each employee will be treated with respect, trust and integrity.
We are responsible to the communities in which we work, live and distribute our products. We will be good citizens. We will develop our employees to reflect the following cultural traits:
- to be value driven
- to help others succeed
- to focus on results
- to embrace change
- to be proactive
We are ultimately responsible to our investors and business partners. Our business will maintain a culture of delivering strong profitability along with the highest degree of quality and safety. We will experiment with new ideas, implement a culture of innovation, expand into new markets and maintain an entrepreneurial environment.
Our management culture is driven by highly principled leaders, who will employ a full participative management approach, encouraging all innovative ideas. We will maintain a commitment to quality. We see our patients as family and will do everything to protect their safety. We will invest into new markets addressing the needs of the community and will become the industry vendor of choice. Our employees will enjoy an atmosphere that fosters development and growth for they are our most valuable assets.
Ernesto Samuel, Chief Executive Officer
With over twenty-five years of successful scientific and technical leadership, Ernesto Samuel is a highly accomplished executive. Since his career foundation as a pharmacist and chemist in the pharmaceutical and cosmetic industries, he has consistently developed high performance teams, often exceeding shareholders and investor’s expectations. His entrepreneurial spirit demonstrates strong strategic planning and management skills. Samuel most recently served as Vice President of Production, Pharmacy, Manufacturing, Quality Assurance and Regulatory for IBA Molecular, a global leader in PET Radiopharmaceutical drugs. Implementing his vision with effective leadership, he designed and managed the transformation of pharmacies nationwide to full manufacturing facilities based on CGMP standards. In less than two years, he upgraded facilities, trained personal and created a new company culture. He established the company as a frontrunner in the industry. A key accomplishment was the negotiations to create a partnership with a leading pharmaceutical company to manufacturer their new innovative radiopharmaceutical drug encompassing all aspects of cost, revenue, quality platforms and supply chain. He has served as board member of Pharmalogics Montreal, a leading PET radiopharmaceutical manufacturer. Samuel has also acted as youth career advisor and provides continued community counseling on self-improvement. Following the 2010 earthquake in Haiti, he adopted an orphanage, offering support to 23 children. In addition, he has supplied pharmacy and medical support to Third World countries. Samuel earned an M.B.A. from The College of St. Rose, NY and a B.S. in Pharmacy from St. John’s University, NY.
Elmise Jean-Pierre, Chief Medical Officer
Dr. Elmise Jean-Pierre contributes to the executive team with expertise in pharmacology, drug interactions, and drug-disease interactions as both a licensed physician and pharmacist. Throughout her career, she has shown a passion for saving lives and improving quality of life. She has accrued a wide variety of professional experiences in family practice, medical clinics and pain management facilities, as well as an emergency room physician and hospitalist. Dr. Jean-Pierre strengths are found in her communication skills with patients, family members and coworkers. She is a strong advocate of patient counseling and is a champion of Drug Utilization Management. She has been Board Certified in Internal Medicine for 10 years. Additionally, Dr. Jean-Pierre has worked as a hospital and community pharmacist for 11 years, including in the role of pharmacy manager. She serves as the Director of Medical Outreach in her community and leads the Health Nugget program, speaking publically on its behalf. She has hosted community medical fairs as well as provided medical support for underprivileged families in the Schenectady community. In addition, she is has provided overseas medical missions and is a co-sponsor of an orphanage in Haiti. Dr. Jean Pierre holds a BSC in pharmacy from St. John’s University, NY and a Doctor of Medicine from Ross University, completing her residency at New York Hospital. She is fluent in French.
John Mather, Director of Analytical Services and Technical Support
Previously Director of Quality Assurance with IBA Molecular, John Mather has extensive knowledge of the FDA and other regulatory agencies and has been the liaison with those agencies. He recently built a quality program to oversee the manufacture of radiopharmaceuticals, successfully transitioned eleven pharmacies to full GMP and filed three ANDAs as required by the FDA. With over 25 years of experience in the pharmaceutical industry, Mather has previously served as Director of Production and Quality Control Manager and has experience with international pharmaceutical manufacturing requirements. He also has extensive analytical chemistry experience in both pharmaceutical quality control and R&D and has been responsible for the quality of raw materials, bulk pharmaceutical ingredients and both sterile and nonsterile final products. John Mather received an MS in chemistry from Hull University (UK).